评估美国放射学会甲状腺影像报告和数据系统(ACR TI-RADS™)及针对儿童甲状腺结节管理建议的修改
该回顾性研究评估了116个儿童甲状腺结节,其中18个(15.5%)为恶性。按成人ACR TI-RADS™标准,15个(83.3%)恶性结节会接受细针穿刺(FNA),3个(16.7%)恶性结节会被延迟诊断;降低尺寸阈值后无恶性结节漏诊,但FNA从24个(24.5%)增至36个(36.7%),随访超声从14个(14.3%)增至62个(63.3%)。作者认为需更大规模多中心研究进一步调整指南。
要点
- 儿童甲状腺结节恶性率15.5%,多数恶性结节(94.4%)为ACR TI-RADS™ 4类和5类。
- 成人ACR TI-RADS™标准下,3个(16.7%)恶性结节未推荐FNA而延迟诊断。
- 降低尺寸阈值可避免漏诊恶性结节,但FNA和随访超声数量显著增加。
核心结论
- 对ACR TI-RADS™指南降低尺寸阈值的潜在修改可早期发现儿童恶性结节,但代价是活检或超声检查数量显著增加;在获得认可和普遍应用前,需更大规模多中心研究进一步调整指南。
研究设计与样本
- 回顾性研究,纳入2006年1月至2021年8月在一家三级儿科机构接受甲状腺结节超声评估的18岁以下儿童,共116个结节;记录最大径、最大ACR TI-RADS™评分和最终诊断,比较成人ACR TI-RADS™标准与修改尺寸阈值后的管理建议。
关键影像表现/征象
- 116个结节中18个(15.5%)为恶性,其中17个(94.4%)为ACR TI-RADS™ 4类或5类。
- 按成人ACR TI-RADS™标准,24个(24.5%)良性结节和15个(83.3%)恶性结节会接受FNA。
- 按成人ACR TI-RADS™标准,14个(14.3%)良性结节和3个(16.7%)恶性结节会接受随访。
- 按成人ACR TI-RADS™标准,60个(61.2%)良性结节和0个恶性结节会被排除。
- 降低尺寸阈值后,无恶性结节在初诊时被漏诊,但FNA从24个(24.5%)增至36个(36.7%),随访超声从14个(14.3%)增至62个(63.3%)。
诊断标准与关键数值
- 基于成人ACR TI-RADS™标准,15个(83.3%)恶性结节会接受FNA,3个(16.7%)恶性结节未推荐FNA而延迟诊断。
- 降低ACR TI-RADS™指南尺寸阈值后,无恶性结节在初诊时被漏诊。
- 诊断性能统计包括敏感度、特异度、准确度、阳性/阴性预测值,均以95%置信区间(CI)表示,采用Clopper-Pearson或标准logit方法。
临床应用与阅片要点
- 儿童甲状腺结节评估可参考ACR TI-RADS™分类,但成人尺寸阈值可能延迟部分恶性结节的诊断。
- 降低尺寸阈值可减少恶性结节漏诊,但会显著增加FNA和随访超声的数量。
局限性
- 原文结论指出需更大规模多中心研究进一步调整指南后,才可推荐其被接受和普遍用于儿科人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Thyroid nodules are unusual in children, but when present, they carry a higher risk for malignancy, as compared to adults. Several guidelines have been created to address the risk stratification for malignancy of thyroid nodules in adults, but none has been completely validated in children. A few authors have proposed lowering the size threshold to the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR TI-RADS™) management guidelines to decrease missed carcinomas at presentation in children; however, little information is known regarding their accuracy.
OBJECTIVE: To assess the performance of proposed modifications of the ACR TI-RADS™ size criteria to guide management decisions in pediatric thyroid nodules and to assess the associated increase in number of fine needle aspiration (FNA) and follow-up exams.
MATERIALS AND METHODS: This is a retrospective study of children under 18 years old who underwent ultrasound assessment of a thyroid nodule at a tertiary care pediatric institution between January 2006 and August 2021. The largest dimension, maximum ACR TI-RADS™ score, and final thyroid nodules' diagnoses were documented. The course of action based on the adult ACR TI-RADS™ and after modifying the size threshold for management recommendations was documented and compared. Statistics included descriptive analysis, weighted Kappa statistics, sensitivity, specificity, accuracy, and positive/negative predictive values of the ACR TI-RADS™ presented with 95% confidence intervals (CI) using either Clopper-Pearson or standard logit methods.
RESULTS: Of 116 nodules, 18 (15.5%) were malignant. Most malignant nodules (94.4%, n = 17) were ACR TI-RADS™ 4 and ACR TI-RADS™ 5 categories. Based on the adult ACR TI-RADS™ criteria, 24 (24.5%) benign and 15 (83.3%) malignant nodules would have undergone FNA; 14 (14.3%) benign and 3 (16.7%) malignant nodules would have been followed up; and 60 (61.2%) benign and none of malignant nodules would have been dismissed. Three (16.7%) malignant nodules would not have been recommended FNA at presentation, delaying their diagnoses. By lowering the size-threshold criteria of the ACR TI-RADS™ guidelines, no malignancy would have been missed at presentation, but this also resulted in a higher number of FNA from 24 (24.5%) to 36 (36.7%) and follow-up ultrasound exams from 14 (14.3%) to 62 (63.3%).
CONCLUSION: Applying potential modifications to the ACR TI-RADS™ guideline lowering the size threshold criteria of the thyroid nodule to guide management decisions for pediatric thyroid nodules can lead to early detection of malignant nodules in children, but at the cost of a significantly increased number of biopsies or ultrasound exams. Further tailoring of the guideline with larger multicentric studies is needed, before warranting its acceptance and general use in the pediatric population.
引用
- Marzukie MS, Shapira-Zaltsberg G, Martinez-Rios C, et al. Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS™) with modification of the management recommendations for pediatric thyroid nodules. Pediatr Radiol. 2024. PMID: 38981907. doi:10.1007/s00247-024-05982-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。